The Challenging Anticoagulant Therapy in Patient with COVID-19-Associated Coagulopathy

The Challenging Anticoagulant Therapy in Patient with COVID-19-Associated Coagulopathy

COVID-19 became a widespread infectious disease in late 2019. Indonesia currently has the highest COVID-19 mortality rate in Asia, between 4-5 percent. Interestingly, COVID-19-associated coagulopathy characterized by an increase of several procoagulant factor levels, including fibrinogen and D-dimer...

Full description

Saved in:
Bibliographic Details
Main Authors: Raissa Virgy Rianda, Mohammad Subkhan, Aditya Doni Pradana, Fahrun Nisa’i Fatimah, Rama Azalix Rianda, Muhammad Perdana Airlangga, Muhammad Miftahussurur
Format: Article
Language:English
Published: Interna Publishing 2021-10-01
Series:Acta Medica Indonesiana
Subjects:
COVID-19
Coagulopathy
Fondaparinux
Anticoagulation
Thrombosis
Online Access:http://www.actamedindones.org/index.php/ijim/article/view/1606
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.actamedindones.org/index.php/ijim/article/view/1606

Similar Items